Evidence map›Paper›PMID 35671074›Full record

ArticleJMIR cancer2022

Timing and Motivations for Alternative Cancer Therapy With Insights From a Crowdfunding Platform: Cross-sectional Mixed Methods Study.

John Peterson, Trevor Wilson, Joshua Gruhl, Sydney Davis, Jaxon Olsen, Matthew Parsons, Benjamin Kann, Angela Fagerlin, Melissa Watt, Skyler Johnson

Open access · goldAbstract read
In one paragraph

Article in JMIR cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. GoFundMe®: Crowdfunding Among Young Adult Patients With Cancer.Clinical journal of oncology nursing · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

John Peterson *Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0001-6516-5779
Trevor Wilson *Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-1311-2998
Joshua GruhlDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-3159-9936
Sydney DavisDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-4064-556X
Jaxon OlsenDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-0145-8649
Matthew ParsonsDepartment of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-1543-5309
Benjamin KannDepartment of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.ORCID https://orcid.org/0000-0002-4313-2754
Angela FagerlinDepartment of Population Sciences, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-9192-2777
Melissa Watt *Department of Population Sciences, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0003-1317-3536
Skyler Johnson *Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, United States.ORCID https://orcid.org/0000-0002-8881-7706
University of Utah · USBrigham and Women's Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAlternative cancer therapy is associated with increased mortality, but little is known about those who pursue it.

objectiveWe aimed to describe individuals' motivations for using alternative cancer therapies and determine whether motivations differ based on individuals' timing of seeking alternative therapies.

methodsWe used data from 649 campaigns posted on the website GoFundMe between 2011 and 2019 for beneficiaries with cancer pursuing alternative therapy. The data were analyzed using a mixed methods approach. Campaigns were categorized by timing of alternative therapy (either before or after experiencing conventional therapy). Qualitative analysis identified motivational themes. Chi-square tests of independence and Fisher tests (all 2-sided) determined significant differences in the presence of motivational themes between groups.

resultsThe expression of concerns about the efficacy of conventional therapy was significantly more likely in campaigns for individuals who used conventional therapy first than in campaigns for individuals who started with alternative therapy (63.3% vs 41.7%; P<.001). Moreover, on comparing those who started with alternative therapy and those who switched from conventional to alternative therapy, those who started with alternative therapy more often expressed natural and holistic values (49.3% vs 27.0%; P<.001), expressed an unorthodox understanding of cancer (25.5% vs 16.4%; P=.004), referenced religious or spiritual beliefs (15.1% vs 8.9%; P=.01), perceived alternative treatment as efficacious (19.1% vs 10.2%; P=.001), and distrusted pharmaceutical companies (3.2% vs 0.5%; P=.04).

conclusionsIndividuals sought treatments that reflected their values and beliefs, even if scientifically unfounded. Many individuals who reported prior conventional cancer therapy were motivated to pursue alternative treatments because they perceived the conventional treatments to be ineffective.

Indexed as

alternative medicinehealth misinformationinternetinternet research ethicsonline crowdfunding

Identifiers

PMID35671074
PMCPMC9214612
OpenAlexW4282941457

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.